Reagents and consumables
Ended Awarded Last action
- Contract number
- 75N91021F00001
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $62,594
Award facts
- Contract value 100% obligated
- $62,593.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on March 17, 2021, for reagents and consumables, with a ceiling value of $62,593.75. The order was priced on a firm fixed-price basis with no set-aside designation. Place of performance is Castleton, IN 46256, with an ultimate completion date of April 16, 2021.
Quick answers
Who was awarded contract 75N91021F00001?
75N91021F00001 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on March 17, 2021.
How much is contract 75N91021F00001 worth?
The government has obligated $62,594 on 75N91021F00001.
Is contract 75N91021F00001 an order under another contract?
Yes. 75N91021F00001 is a delivery order under 75N91019D00038, an indefinite delivery contract.
Was contract 75N91021F00001 competed?
The extent of competition for 75N91021F00001 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award